[Ganoderic acid A suppresses proliferation and invasion and induces apoptosis in human osteosarcoma cells]

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Osteosarcoma is a primary bone malignancy with limited treatment options.
• Ganoderic acid A (GA-A), a compound from Ganoderma lucidum, has shown potential anti-cancer properties.

Purpose of the Study:

• To evaluate the in vitro effects of GA-A on human osteosarcoma cell lines (MG63 and HOS).
• To investigate GA-A's impact on cell proliferation, apoptosis, and invasion.

Main Methods:

• Cells were treated with varying concentrations of GA-A (0.1, 0.25, 0.5 mmol/L).
• Cell proliferation, apoptosis, and invasion were assessed using MTT, flow cytometry, and Transwell assays.
• Protein expression levels of STAT3, p38, and NF-κB1 were analyzed via Western blotting.

Main Results:

• GA-A significantly inhibited osteosarcoma cell proliferation in a dose-dependent manner.
• GA-A treatment induced notable apoptosis in both MG63 and HOS cells.
• GA-A suppressed cell invasion and modulated the expression of STAT3, p38, and NF-κB1 signaling pathways.

Conclusions:

• GA-A demonstrates significant anti-proliferative, pro-apoptotic, and anti-invasive effects on human osteosarcoma cells in vitro.
• These findings suggest GA-A as a potential therapeutic agent for osteosarcoma treatment.